April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
April 12, 2024 Banks Brace for Earnings Amid Rate Cut Speculations
Apple’s Technical Climb To $240 By Year-End
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Castle Biosciences (CSTL) stock forecast for 2026
Updated: April 19, 2024 (09:15)
Sector: HealthcareThe share price of Castle Biosciences, Inc. (CSTL) now
50/200 Day Moving Average: $21.71 / $19.03
This figure corresponds to the Average Price over the previous 50/200 days. For Castle Biosciences stocks, the 50-day moving average is the resistance level today.
For Castle Biosciences stocks, the 200-day moving average is the resistance level today.
Are you interested in Castle Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Castle Biosciences stock price in 2026. How much will one Castle Biosciences share be worth in 2026? Is it worth taking profit / loss on CSTL stock now or waiting? What are analysts' forecasts for Castle Biosciences stock?
We forecast Castle Biosciences stock performance using neural networks based on historical data on CSTL stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Castle Biosciences, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Castle Biosciences analysts is $33.11. Today 200 Day Moving Average is the support level (19.03 $). 50 Day Moving Average is the resistance level (21.71 $).
Historical and forecast chart of Castle Biosciences, Inc. stock
The chart below shows the historical price of Castle Biosciences stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CSTL stock price can be found in the table below.
Castle of Biological Sciences, Inc., a commercial stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its flagship product is DecisionDx-Melanoma, a Multiple Gene Expression Profile (GEP) test for identifying Stage I and II patients at high risk of metastasis, based on biological information from 31 genes in their tumor tissue. The company also offers the DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis in patients with uveal melanoma, a rare eye cancer; and two late-stage proprietary products that address squamous cell skin cancer and suspicious pigmented lesions, which are highly clinical indications for dermatological cancer. It offers testing services through physicians, physician assistants and nurse practitioners. The company was founded in 2007 and is headquartered in Friendswood, Texas.
Castle Biosciences (CSTL) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 30.58 | 28.53 | 32.51 | 12.25 % |
| Feb | 30.80 | 28.86 | 33.73 | 14.44 % |
| Mar | 28.99 | 26.43 | 30.77 | 14.11 % |
| Apr | 31.62 | 30.52 | 34.99 | 12.78 % |
| May | 35.65 | 34.41 | 37.95 | 9.34 % |
| Jun | 39.90 | 38.05 | 41.80 | 8.95 % |
| Jul | 43.69 | 41.06 | 46.39 | 11.47 % |
| Aug | 38.25 | 36.86 | 40.66 | 9.35 % |
| Sep | 39.05 | 37.19 | 41.19 | 9.69 % |
| Oct | 41.08 | 39.70 | 43.84 | 9.45 % |
| Nov | 39.12 | 35.45 | 42.41 | 16.40 % |
| Dec | 40.60 | 37.99 | 41.96 | 9.48 % |
Castle Biosciences information and performance
820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US
Market capitalization of the Castle Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CSTL shares in the company outstanding by the market price of one share.
EBITDA of Castle Biosciences is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Castle Biosciences price target for 2026 by month
Target values for the price of one Castle Biosciences share for Jan 2026.
In Jan, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 12.248% volatility is expected.
Pessimistic target level: 28.53
Optimistic target level: 32.51
Target values for the price of one Castle Biosciences share for Feb 2026.
In Feb, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 14.445% volatility is expected.
Pessimistic target level: 28.86
Optimistic target level: 33.73
Target values for the price of one Castle Biosciences share for Mar 2026.
In Mar, the Negative dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 14.111% volatility is expected.
Pessimistic target level: 26.43
Optimistic target level: 30.77
Target values for the price of one Castle Biosciences share for Apr 2026.
In Apr, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 12.780% volatility is expected.
Pessimistic target level: 30.52
Optimistic target level: 34.99
Target values for the price of one Castle Biosciences share for May 2026.
In May, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 9.339% volatility is expected.
Pessimistic target level: 34.41
Optimistic target level: 37.95
Target values for the price of one Castle Biosciences share for Jun 2026.
In Jun, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 8.954% volatility is expected.
Pessimistic target level: 38.05
Optimistic target level: 41.80
Target values for the price of one Castle Biosciences share for Jul 2026.
In Jul, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 11.473% volatility is expected.
Pessimistic target level: 41.06
Optimistic target level: 46.39
Target values for the price of one Castle Biosciences share for Aug 2026.
In Aug, the Negative dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 9.351% volatility is expected.
Pessimistic target level: 36.86
Optimistic target level: 40.66
Target values for the price of one Castle Biosciences share for Sep 2026.
In Sep, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 9.691% volatility is expected.
Pessimistic target level: 37.19
Optimistic target level: 41.19
Target values for the price of one Castle Biosciences share for Oct 2026.
In Oct, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 9.445% volatility is expected.
Pessimistic target level: 39.70
Optimistic target level: 43.84
Target values for the price of one Castle Biosciences share for Nov 2026.
In Nov, the Negative dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 16.402% volatility is expected.
Pessimistic target level: 35.45
Optimistic target level: 42.41
Target values for the price of one Castle Biosciences share for Dec 2026.
In Dec, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 9.481% volatility is expected.
Pessimistic target level: 37.99
Optimistic target level: 41.96
